{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:03:52Z","timestamp":1791353032435,"version":"4.3.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":3417,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.imbio.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T22:18:11Z","timestamp":1399587491000},"page":"687-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Induction of PD-L1 on monocytes: A new mechanism by which IVIg inhibits mixed lymphocyte reactions"],"prefix":"10.1016","volume":"219","author":[{"given":"Lauriane","family":"Padet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Loubaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Bazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2014.04.001_bib0005","doi-asserted-by":"crossref","first-page":"e60367","DOI":"10.1371\/journal.pone.0060367","article-title":"The role of programmed cell death ligand-1 (PD-L1\/CD274) in the development of graft versus host disease","volume":"8","author":"Al-Chaqmaqchi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2014.04.001_bib0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.seminoncol.2012.10.001","article-title":"Immune tolerance and transplantation","volume":"39","author":"Alpdogan","year":"2012","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0015","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1182\/blood-2002-03-0985","article-title":"Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation","volume":"100","author":"Antin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2014.04.001_bib0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.immunol.16.1.27","article-title":"Interleukin-1 receptor antagonist: role in biology","volume":"16","author":"Arend","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0025","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2009-06-225417","article-title":"Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation","volume":"115","author":"Aubin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2014.04.001_bib0030","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4049\/jimmunol.171.3.1272","article-title":"Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism","volume":"171","author":"Blazar","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","article-title":"Exosome secretion: molecular mechanisms and roles in immune responses","volume":"12","author":"Bobrie","year":"2011","journal-title":"Traffic"},{"key":"10.1016\/j.imbio.2014.04.001_bib0040","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.1100766","article-title":"IL-6 promotes cardiac graft rejection mediated by CD4+ cells","volume":"187","author":"Booth","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0045","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/lt.20594","article-title":"High dose intravenous immunoglobulin treatment: mechanisms of action","volume":"11","author":"Boros","year":"2005","journal-title":"Liver Transpl."},{"key":"10.1016\/j.imbio.2014.04.001_bib0050","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4049\/jimmunol.165.3.1352","article-title":"CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression","volume":"165","author":"Carreno","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00007890-200101150-00009","article-title":"A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection","volume":"71","author":"Casadei","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.imbio.2014.04.001_bib0060","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.imbio.2014.04.001_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2249.2011.04390.x","article-title":"Key aspects for successful immunoglobulin therapy of primary immunodeficiencies","volume":"164","author":"Cunningham-Rundles","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","article-title":"Inflammatory cytokines as a third signal for T cell activation","volume":"22","author":"Curtsinger","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0075","first-page":"1015","article-title":"PD-1\/PD-L1, PD-1\/PD-L2, and other co-inhibitory signaling pathways in transplantation","volume":"21","author":"del Rio","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.imbio.2014.04.001_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clim.2008.08.018","article-title":"The effects of IL-6 on CD4T cell responses","volume":"130","author":"Dienz","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/35051100","article-title":"ICOS co-stimulatory receptor is essential for T-cell activation and function","volume":"409","author":"Dong","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2014.04.001_bib0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00251-011-0590-0","article-title":"TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition","volume":"64","author":"D\u2019Orsogna","year":"2012","journal-title":"Immunogenetics"},{"key":"10.1016\/j.imbio.2014.04.001_bib0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ni1057","article-title":"Membranes as messengers in T cell adhesion signaling","volume":"5","author":"Dustin","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0100","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M","article-title":"The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance","volume":"32","author":"Eagar","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2014.04.001_bib0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0966-3274(02)00055-2","article-title":"Pathways of allorecognition: implications for transplantation tolerance","volume":"10","author":"Game","year":"2002","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/bmt.2011.93","article-title":"Use of immunoglobulins in the prevention of GvHD in a xenogeneic NOD\/SCID\/gammac- mouse model","volume":"47","author":"Gregoire-Gauthier","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.imbio.2014.04.001_bib0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-6143.2010.03400.x","article-title":"Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients","volume":"11","author":"Jordan","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2014.04.001_bib0125","first-page":"133","article-title":"Evidence for immunosuppression by high-dose gammaglobulin","volume":"15","author":"Kawada","year":"1987","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","volume":"203","author":"Keir","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2014.04.001_bib0135","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-3083.1993.tb02591.x","article-title":"Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro","volume":"38","author":"Klaesson","year":"1993","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.imbio.2014.04.001_bib0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1684\/ecn.2009.0181","article-title":"Early pre-engraftment, functional, in vitro responsiveness of T lymphocytes in allotransplanted, acute leukemia patients: proliferation and release of a broad profile of cytokines, possibly predictive of graft-versus-host disease","volume":"21","author":"Liseth","year":"2010","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.imbio.2014.04.001_bib0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.2001.02741.x","article-title":"Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis","volume":"113","author":"Mollee","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/25764","article-title":"Three-dimensional segregation of supramolecular activation clusters in T cells","volume":"395","author":"Monks","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2014.04.001_bib0160","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.transproceed.2011.12.032","article-title":"Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation","volume":"44","author":"Nakagiri","year":"2012","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.imbio.2014.04.001_bib0165","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2249.2011.04476.x","article-title":"Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?","volume":"166","author":"Padet","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.imlet.2012.12.011","article-title":"IVIg prevents the in vitro activation of T cells by neutralizing the T cell activators","volume":"150","author":"Padet","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imbio.2014.04.001_bib0175","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0180","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/00007890-199612150-00024","article-title":"Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation","volume":"62","author":"Peraldi","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.imbio.2014.04.001_bib0185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/jir.2007.0145","article-title":"Interferon gamma enhances clonal expansion and survival of CD4+ T cells","volume":"28","author":"Reed","year":"2008","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.imbio.2014.04.001_bib0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1703111","article-title":"Chronic graft-versus-host disease: clinical manifestation and therapy","volume":"28","author":"Ratanatharathorn","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.imbio.2014.04.001_bib0195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/0929867003374778","article-title":"The impact of immunosuppressive drugs on the analysis of T cell activation","volume":"7","author":"Rovira","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.imbio.2014.04.001_bib0200","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5812\/numonthly.1806","article-title":"Efficacy of anti-interleukin-2 receptor antibody (daclizumab) in reducing the incidence of acute rejection after renal transplantation","volume":"4","author":"Saghafi","year":"2012","journal-title":"Nephrourol. Mon."},{"key":"10.1016\/j.imbio.2014.04.001_bib0205","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.4049\/jimmunol.174.6.3408","article-title":"Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo","volume":"174","author":"Sandner","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0210","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-3083.1998.00299.x","article-title":"Down-regulation of lymphokine synthesis by intravenous gammaglobulin is dependent upon accessory cells","volume":"47","author":"Skansen-Saphir","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0215","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1182\/blood-2009-06-204669","article-title":"Acute graft-versus-host disease: from the bench to the bedside","volume":"114","author":"Socie","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2014.04.001_bib0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0225","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/bbmt.2002.v8.pm11939601","article-title":"Intravenous immunoglobulin: appropriate indications and uses in hematopoietic stem cell transplantation","volume":"8","author":"Sokos","year":"2002","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.imbio.2014.04.001_bib0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJM199009133231103","article-title":"Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation","volume":"323","author":"Sullivan","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.imbio.2014.04.001_bib0235","first-page":"43","article-title":"Immunomodulation in allogeneic marrow transplantation: use of intravenous immune globulin to suppress acute graft-versus-host disease","volume":"104","author":"Sullivan","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0240","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.4049\/jimmunol.179.8.5204","article-title":"PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection","volume":"179","author":"Tanaka","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0245","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/00007890-199611150-00020","article-title":"Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins","volume":"62","author":"Toungouz","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.imbio.2014.04.001_bib0250","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0966-3274(94)90012-4","article-title":"Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin","volume":"2","author":"Toyoda","year":"1994","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0255","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1600-6143.2003.00011.x","article-title":"Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells","volume":"3","author":"Toyoda","year":"2003","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2014.04.001_bib0260","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2012-07-445007","article-title":"Intravenous immunoglobulin (IVIg) inhibits CD8 cytotoxic T-cell activation","volume":"120","author":"Trepanier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2014.04.001_bib0265","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood-2012-11-468264","article-title":"Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells","volume":"122","author":"Trinath","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2014.04.001_bib0270","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199402270-00014","article-title":"Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ","volume":"57","author":"Tyan","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.imbio.2014.04.001_bib0275","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jlb.67.1.2","article-title":"CD40-CD40 ligand","volume":"67","author":"van Kooten","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0280","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.4049\/jimmunol.157.9.4258","article-title":"Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD","volume":"157","author":"Via","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0285","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.4049\/jimmunol.167.9.5457","article-title":"Donor IFN-gamma receptors are critical for acute CD4(+) T cell-mediated cardiac allograft rejection","volume":"167","author":"Wiseman","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2014.04.001_bib0290","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MOT.0b013e32835a4c0d","article-title":"Belatacept in kidney transplantation","volume":"17","author":"Wojciechowski","year":"2012","journal-title":"Curr Opin Organ Tranplant."},{"key":"10.1016\/j.imbio.2014.04.001_bib0295","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbmt.2011.11.016","article-title":"IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy","volume":"18","author":"Yarkoni","year":"2012","journal-title":"Biol. Blood Marrow Transplant."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298514000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298514000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:37:36Z","timestamp":1759250256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298514000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0171298514000837"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2014.04.001","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of PD-L1 on monocytes: A new mechanism by which IVIg inhibits mixed lymphocyte reactions","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2014.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}